Variable | Freq (%) | Anaemia | Mean (±sd) PCV | χ² | P-value | OR | 95% CI | t-test | P-value | |
---|---|---|---|---|---|---|---|---|---|---|
None/Mild n (%) | Moderate/Severe n (%) | |||||||||
Parasitaemia | 22 (19.5) | 3 (14.3) | 19 (90.5) | 26.8 (6.6) | 2.33 | 0.13 | 3.11 | 0.85–11.36 | −2.60 | 0.007 |
No parasitaemia | 91 (80.5) | 30 (32.6) | 61 (66.3) | 30.8 (6.0) | ||||||
Education | ||||||||||
 None | 5 (4.4) | 1 (20.0) | 4 (80.0) | 29.6 (5.5) | 0.00 | 1.00 | 1.68 | 0.18–15.66 | – | – |
 Primary | 13 (11.5) | 1 (7.0) | 12 (92.3) | 28.9 (4.1) | 2.22 | 0.14 | 5.65 | 0.70–45.33 | 0.26 | 0.40 |
 Secondary | 51 (45.1) | 18 (35.3) | 33 (64.7) | 29.9 (6.2) | 1.67 | 0.20 | 0.58 | 0.26–1.32 | −0.12 | 0.46 |
 Tertiary | 44 (39.0) | 13 (29.6) | 31 (70.5) | 30.6 (7.0) | 0.004 | 0.95 | 0.97 | 0.42–2.23 | −0.37 | 0.36 |
Pregnancy | ||||||||||
 1st | 32 (28.3) | 11 (34.4) | 21 (65.7) | 29.6 (6.3) | 0.58 | 0.45 | 0.71 | 0.30–1.71 | −0.46 | 0.33 |
 > 1st | 81 (71.7) | 22 (27.1) | 59 (72.8) | 30.2 (6.3) |  |  |  |  |  |  |
Trimester | ||||||||||
 First | 19 (16.8) | 5 (15.1) | 14 (17.5) | 30.9 (7.2) | 0.09 | 0.76 | 1.19 | 0.39, 3.61 | – | – |
 Second | 54 (47.8) | 15 (45.5) | 39 (48.7) | 29.5 (6.3) | 0.10 | 0.75 | 1.14 | 0.51, 2.57 | 0.75 | 0.23 |
 Third | 40 (35.4) | 13 (39.4) | 27 (33.8) | 30.4 (5.9) | 0.33 | 0.57 | 0.78 | 0.34, 1.81 | 0.26 | 0.60 |
Age (years) | ||||||||||
 ≤ 20 | 4 (3.5) | 1 (25.0) | 3 (75.0) | 30.3 (5.4) | 0.00 | 1.00 | 1.25 | 0.12–12.44 | – | – |
 21–25 | 24 (21.2) | 10 (41.7) | 14 (58.4) | 30.3 (7.4) | 2.29 | 0.13 | 0.49 | 0.19–1.25 | 0.0 | 1.00 |
 26–30 | 36 (31.9) | 6 (16.7) | 30 (83.3) | 29.1 (5.1) | 4.02 | 0.04 | 2.70 | 1.00–7.29 | 0.42 | 0.35 |
 31–35 | 31 (27.4) | 8 (25.8) | 23 (74.2) | 29.9 (7.1) | 0.24 | 0.62 | 1.26 | 0.50–3.20 | 0.13 | 0.45 |
 > 35 | 18 (159) | 8 (44.5) | 10 (55.6) | 31.9 (5.6) | 2.40 | 0.12 | 0.45 | 0.16–1.26 | −0.53 | 0.31 |
ITN | ||||||||||
 Use | 15 (13.3) | 5 (33.3) | 10 (66.7) | 30.5 (6.5) | 0.14 | 0.71 | 0.80 | 0.25–2.55 | 0.28 | 0.39 |
 Non-use | 98 (86.7) | 28 (28.6) | 70 (71.4) | 30.0 (6.3) |  |  |  |  |  |  |
Anti-malarial | ||||||||||
 Use | 55 (48.7) | 17 (30.9) | 38 (69.1) | 29.4 (6.2) | 0.15 | 0.70 | 0.85 | 0.38–1.92 | −1.01 | 0.16 |
 Non-use | 58 (51.3) | 16 (27.6) | 42 (72.4) | 30.6 (6.4) |  |  |  |  |  |  |
IPTp | ||||||||||
 Use | 32 (28.3) | 12 (37.5) | 20 (62.5) | 30.3 (6.7) | 1.49 | 0.22 | 0.58 | 0.24–1.39 | 0.29 | 0.39 |
 Non-use | 81 (71.7) | 21 (25.9) | 60 (74.1) | 29.9 (6.1) |  |  |  |  |  |  |
Herb | ||||||||||
 Use | 33 (29.2) | 7 (21.2) | 26 (78.8) | 28.2 (5.2) | 1.44 | 0.23 | 1.79 | 0.69–4.66 | −2.23 | 0.01 |
 Non-use | 80 (70.8) | 26 (32.5) | 54 (67.5) | 30.8 (6.6) |  |  |  |  |  |  |